Abnormal ocular staining scores showed a substantial number of dry eye patients with keratoconjunctivitis sicca that was distinct from Sjögren's syndrome. The new method of assessing ...
WASHINGTON — A nanomicellar formulation of cyclosporine A was well tolerated with a low rate of ocular adverse events or instillation site pain, according to a study presented here. Luchs reported the ...
This page lists all known medications that could potentially lead to 'Keratitis sicca' as a side effect. It's important to note that mild side effects are quite common with medications. The medication ...
New York, March 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Keratoconjunctivitis Sicca (Dry Eye) Clinical Trial Analysis by Trial Phase, Trial Status, Trial ...
DUBLIN--(BUSINESS WIRE)--The "Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an ...
PUNE, India, May 11, 2017 /PRNewswire-iReach/ -- Latest report Keratoconjunctivitis sicca Pipeline Market Review, H1 2017 is added to ReportsnReports.com store. The report provides comprehensive ...
NEW YORK, Oct. 11, 2017 /PRNewswire/ -- SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2017, ...
DUBLIN--(BUSINESS WIRE)--The "Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, 2022" clinical trials has been added to ResearchAndMarkets.com's offering. Keratoconjunctivitis ...
(MENAFN- GlobeNewsWire - Nasdaq) Discover pivotal insights with the "Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, 2025." This comprehensive report offers a snapshot of global ...
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Keratoconjunctivitis Sicca (Dry Eye) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results